Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business

05-Feb-2008

Neurochem Inc. announced that Mr. Gary Schmid will join Neurochem, effective February 4, 2008, and will serve as Chief Executive Officer (CEO) of the new business Neurochem has announced it is creating to develop and market nutraceuticals. Mr. Schmid joins the Company from Santé Naturelle A.G. Limited. Mr. Schmid joined Santé Naturelle in May 2006 as Chief Operating Officer and was appointed President and CEO later that year. In addition, Mr. Schmid spent 20 years at Abbott Laboratories Ltd. in a variety of positions of ever-increasing responsibility in sales and marketing where, in 2005, he was appointed General Manager, Abbott Nutrition.

As President and CEO of Santé Naturelle A.G., Mr. Schmid succeeded in developing and implementing that company's strategies to support future growth expectations, which translated into significantly increasing sales in domestic and export business segments and in the launch of 35 new products within 12 months.

Before joining Santé Naturelle, Mr. Schmid held positions with Abbott Laboratories Ltd. (Canada), where he served between 1985 and 2006, initially as a financial analyst with what was to become Abbott's nutrition division, and then rapidly moved into sales and marketing. Following a two-year assignment with Abbott International Ltd. in Chicago, Mr. Schmid returned to Canada in 1994 as National Sales Manager of the future nutrition division, progressed to a series of more responsible positions in marketing, including Marketing Director of Abbott's Pharma Division, before being appointed General Manager, Abbott Nutrition, in 2005. Mr. Schmid is a Commerce graduate of McGill University.

https://www.bionity.com/en/news/77292/neurochem-appoints-mr-gary-schmid-as-ceo-of-new-nutraceutical-business.html